Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy

NCT02310867 is registered in ClinicalTrials.gov with Linda Cendales as lead sponsor.

NCT NCT02310867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02310867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
Lead sponsor
Linda Cendales
Phase
Phase 2
Overall status
Recruiting
Start date
March 31, 2015
Completion date
June 30, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression